Nanomedicines for Overcoming Cancer Drug ResistanceTingting Hu, Zhiyao He, Yuan Huang et al.|Pharmaceutics|2022Cited by 49
The role of interferons in ovarian cancer progression: Hinderer or promoter?Taiqing Liu, Zhiyao He, Yinqi Li et al.|Frontiers in Immunology|2022Cited by 21
Simultaneous enhancement of cellular and humoral immunity by the high salt formulation of Al(OH)3 adjuvantMin Luo, Xiawei Wei, Bin Shao et al.|Cell Research|2017Cited by 20
Multifunctional Mitochondria-Targeting Nanosystems for Enhanced Anticancer EfficacyTingting Hu, Zhiyao He|Frontiers in Bioengineering and Biotechnology|2021Cited by 18
Anlotinib Suppressed Ovarian Cancer Progression via Inducing G2/M Phase Arrest and ApoptosisYanghui Zhu, Zhiyao He|Journal of Clinical Medicine|2022Cited by 7